1-es típusú cukorbetegség: vizsgálatok itt: Kanada
42 of 52 trials · From ClinicalTrials.gov, checked 2026. november 18.. Ask the study team whether a trial fits you.
- No phaseTaking peopleFeasibility and Adoption of a Screening Program for T1D Relatives in Canada
- Where
- Montreal
- Életkor
- 18 év and over
- People
- 1000
- Run by
- Institut de Recherches Cliniques de Montreal
See details and how to joinNCT07322380 - No phaseTaking peopleImplementation of Support in the Care of Adults Living With Type 1 Diabetes
- Where
- Montreal, Québec, Terrebonne
- Életkor
- 18 év and over
- People
- 322
- Run by
- McGill University
See details and how to joinNCT06069583 - 3. fázisTaking peopleA Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes
- Where
- Calgary, Halifax, Ottawa, Vancouver
- Életkor
- 1 év to 25 év
- People
- 723 worldwide
- Run by
- Sanofi
See details and how to joinNCT07088068 - 3. fázisTaking peopleA Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
- Where
- Calgary, Guelph, Hamilton, Joliette, Montreal, Stouffville, Surrey, Toronto, Vancouver
- Életkor
- 18 év and over
- People
- 500 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07776509 · EU 2025-523295-23-00 - 3. fázisTaking peopleA Study of Baricitinib (LY3009104) for the Delay of Stage 3 Type 1 Diabetes in At-Risk Children and Adults
- Where
- Calgary, Edmonton, Vancouver
- Életkor
- 1 év to 35 év
- People
- 150 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07222137 · EU 2025-521797-34-00 - 3. fázisTaking peopleA Study of Baricitinib (LY3009104) to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Diabetes (BARICADE-PRESERVE)
- Where
- Calgary, Chicoutimi, Edmonton, London, Ottawa, Québec, Vancouver
- Életkor
- 1 év to 35 év
- People
- 300 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07222332 · EU 2025-522170-36-00 - 3. fázisTaking peopleA Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus
- Where
- Brampton, Calgary, Guelph, Hamilton, Mississauga, Moncton, Montreal, New Westminster, North York, Québec, Saint-Charles-Borromée, Scarborough Village, Sherbrooke, Stoney Creek, Stouffville, Surrey, Toronto, Truro, Victoria
- Életkor
- 18 év and over
- People
- 2500 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07784725 · EU 2025-523379-41-00 - 2/3. fázisTaking peopleLean Mass Changes With Semaglutide in Adults With Type 1 Diabetes and Overweight/Obesity.
- Where
- Montreal
- Életkor
- 18 év to 65 év
- People
- 40
- Run by
- McGill University Health Centre/Research Institute of the McGill University Health Centre
See details and how to joinNCT07891156 - 1/2. fázisTaking peopleVV-14300 for the Treatment of Type 1 Diabetes
- Where
- Toronto
- Életkor
- 18 év to 65 év
- People
- 29 worldwide
- Run by
- Kriya Therapeutics, Inc.
See details and how to joinNCT07831798 - No phaseNot yet taking people in KanadaFunctional Mobility and Resistance Exercise for Postmenopausal Females With Type 1 Diabetes
- Where
- Edmonton, Hamilton, Montreal
- Életkor
- 50 év and over
- People
- 63
- Run by
- Institut de Recherches Cliniques de Montreal
See details and how to joinNCT07851662 - 3. fázisNot yet taking people in KanadaA Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight
- Where
- Brampton, Calgary, Guelph, Halifax, Hamilton, Kelowna, London, Moncton, Montreal, Pointe-Claire, Québec, Sarnia, Surrey, Sydney, Toronto, Victoria
- Életkor
- 18 év and over
- People
- 2500 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07564414 · EU 2025-522488-14-00 - 2. fázisNot yet taking people in KanadaRezpegaldesleukin (NKTR-358) in New Onset Type 1 Diabetes Mellitus
- Where
- Vancouver
- Életkor
- 8 év to 45 év
- People
- 66 worldwide
- Run by
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
See details and how to joinNCT07142252 - 3. fázisTaking peopleA Safety, Tolerability, and Efficacy Study of VX-880 and VX-017 in Participants With Type 1 Diabetes
- Where
- Edmonton, Montreal, Toronto, Vancouver
- Életkor
- 18 év to 65 év
- People
- 57 worldwide
- Run by
- Vertex Pharmaceuticals Incorporated
See details and how to joinNCT04786262 · EU 2024-513929-23-00 - 3. fázisNot yet taking people in KanadaAMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications
- Where
- Calgary, Edmonton, Kelowna, Red Deer, Sarnia, Stouffville, Sydney, Terrebonne, Toronto
- Életkor
- 45 év and over
- People
- 1778 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07797335 - 1. fázisNot yet taking people in KanadaENCRT-103-hPI: Evaluation of an Immune-protected ENCRT-103-hPI Containing Primary Human Islets in Adults With Type 1 Diabetes, With and Without Standard-of-care Portal Vein Islet Infusion.
- Where
- Toronto, Vancouver
- Életkor
- 18 év to 75 év
- People
- 10
- Run by
- Encellin
See details and how to joinNCT07680673 - No phaseNot yet taking people in KanadaNO-Meal Announcement in Automated Insulin Delivery (Open-source and Commercial) Systems
- Where
- Montreal
- Életkor
- 18 év and over
- People
- 33
- Run by
- Institut de Recherches Cliniques de Montreal
See details and how to joinNCT07758647 - No phaseCsak meghívásosIntelligent Care Platform - Quasi-Experimental Trial
- Where
- Vancouver
- Életkor
- 3 év to 18 év
- People
- 80
- Run by
- University of British Columbia
See details and how to joinNCT07712809 - No phaseTaking peopleExercise and the Menstrual Cycle in Type 1 Diabetes
- Where
- Edmonton
- Életkor
- 18 év to 50 év
- People
- 15
- Run by
- University of Alberta
See details and how to joinNCT05188014 - Korai 1. fázisTaking peopleSimultaneous Measurement and Responsive Treatment - Part 2
- Where
- Toronto
- Életkor
- 18 év and over
- People
- 40
- Run by
- ClinSurge Research
See details and how to joinNCT07655076 - 2. fázisTaking peopleTrial of Semaglutide for Diabetic Kidney Disease in Type 1 Diabetes
- Where
- Toronto
- Életkor
- 18 év and over
- People
- 60 worldwide
- Run by
- University of Washington
See details and how to joinNCT05822609 - No phaseTaking peopleType 1 Diabetes, Exercise and Mentoring Trial
- Where
- Mississauga, Winnipeg
- Életkor
- 13 év to 17 év
- People
- 60
- Run by
- University of Manitoba
See details and how to joinNCT06296992 - 2/3. fázisTaking peopleA Clinical Trial Using Tirzepatide to Help Adults With Type 1 Diabetes Automatically Control Their Blood Sugar
- Where
- Montreal
- Életkor
- 18 év and over
- People
- 105 worldwide
- Run by
- McGill University Health Centre/Research Institute of the McGill University Health Centre
See details and how to joinNCT07284511 - No phaseTaking peopleFasted Exercise Training in Type 1 Diabetes (FED-T1D)
- Where
- Edmonton
- Életkor
- 18 év to 55 év
- People
- 20
- Run by
- University of Alberta
See details and how to joinNCT06748963 - No phaseTaking peoplePrebiotics in Patients With Type 1 Diabetes
- Where
- Calgary, Edmonton, Saskatoon
- Életkor
- 7 év and over
- People
- 144
- Run by
- University of Calgary
See details and how to joinNCT04963777 - 2. fázisTaking peopleThe Efficacy, Mechanism & Safety of Sodium Glucose Co-Transporter-2 Inhibitor & Glucagon-Like Peptide 1 Receptor Agonist Combination Therapy in Kidney Transplant Recipients
- Where
- Toronto
- Életkor
- 18 év and over
- People
- 20
- Run by
- University Health Network, Toronto
See details and how to joinNCT05938712